15.11.2016
- Sanofi and US biopharmaceutical company Mannkind have finally thrashed out an agreement to terminate their licensing deal for Afrezza inhalable insulin. The agreement will likely...
03.10.2016
- The world’s biggest insulin producer, Novo Nordisk, has announced plans to cut 1,000 jobs in response to a challenging environment and increased competition, particularly in the US...
01.08.2016
- Long-time Eli Lilly chairman and CEO, John C. Lechleiter, has announced plans to retire in December of this year after 30 years with the US drugmaker. Succeeding the 62-year-old...
04.04.2016
- Analysts love looking into the future, particularly when it comes to big pharma’s prospect for growth and earnings. The industry experts of Morningstar see slowing patent losses...
13.11.2015
- French drugmaker Sanofi has entered into two separate collaborations to develop and commercialize diabetes treatments. An agreement with US-based Lexicon Pharmaceuticals centers on...
05.11.2015
- US drugmaker Eli Lilly plans to expand its research and development headquarters in Indianapolis, Indiana, to the tune of $70 million, adding floor space and a new disciplinary...
29.09.2015
- France’s Sanofi and US drugmaker Eli Lilly have resolved their patent dispute over insulin drugs. The settlement announced this week ends a US lawsuit brought by the French...
21.03.2014
- Novo Nordisk should still be able to introduce its long-acting insulin Tresiba on the U.S. market before rival products, despite being hit by a delay, the CEO of the Danish...
